Latest Commercial Partnerships News

Page 15 of 22
Mesoblast has entered agreements to issue up to US$50 million in convertible notes, aiming to strengthen its capital base and support pipeline growth, pending shareholder approval.
Ada Torres
Ada Torres
4 Sept 2025
Zeotech Limited has completed its largest commercial concrete demonstration using AusPozz™, a low-carbon metakaolin product that reduces cement content and embodied carbon. The 100 cubic metre pour attracted major industry players and opened doors to new commercial trials and partnerships.
Maxwell Dee
Maxwell Dee
1 Sept 2025
Singular Health Group reported a $6.38 million loss for FY2025 while securing a pivotal $1.3 million commercial agreement with US-based Provider Network Solutions to deploy its 3DICOM software. The company also completed a major cloud migration of its platform, positioning itself for growth in the US healthcare market.
Victor Sage
Victor Sage
29 Aug 2025
Streamplay Studio Limited reported a remarkable 201% surge in operating revenue for FY25, driven by its strategic acquisition of Noodlecake Studios and expansion into new markets. Despite a wider operating loss, the company achieved positive cash flow and profitability in the final quarter, signaling a promising turnaround.
Sophie Babbage
Sophie Babbage
29 Aug 2025
Skin Elements Limited reported a 13% revenue increase and a 20% reduction in net loss for FY2025, as it progresses commercial roll-out of its natural biotech products including ECO-Nurture and SuprCuvr.
Ada Torres
Ada Torres
29 Aug 2025
Tetratherix Limited reports its first financial results as a listed company, revealing a $9.4 million statutory loss driven by R&D and listing costs, alongside a robust $29.3 million cash position post-IPO. The company highlights key operational milestones and outlines strategic plans to accelerate commercialisation across its innovative biomaterial platform.
Ada Torres
Ada Torres
28 Aug 2025
Micro-X reported FY25 revenue of $13.1 million, underpinned by significant US government contracts and pioneering 3D head CT imaging technology, setting the stage for clinical trials and commercial expansion.
Victor Sage
Victor Sage
28 Aug 2025
Tetratherix Limited reported a $9.4 million statutory loss for FY25 amid significant R&D and operational investments, successfully listing on the ASX and progressing multiple clinical and manufacturing initiatives.
Ada Torres
Ada Torres
28 Aug 2025
Biotron Limited reported a significantly reduced net loss of $318,572 for FY2025, bolstered by a $1.27 million capital raise and a $1.81 million R&D tax rebate, as it advances clinical and preclinical antiviral programs.
Ada Torres
Ada Torres
27 Aug 2025
Mesoblast Limited is set to release its full-year financial results and operational highlights for 2025, spotlighting its FDA-approved cell therapy and expanding global partnerships.
Ada Torres
Ada Torres
27 Aug 2025
Bio-Gene Technology Limited reported a net loss of AUD 2.58 million for FY2025 while making significant strides in developing its bio-insecticides Flavocide and Qcide, securing US Department of Defense grants and expanding global partnerships.
Ada Torres
Ada Torres
26 Aug 2025
Premier1 Lithium has announced its first inferred mineral resource at the Wadgingarra gold project, marking a significant step towards commercial gold production with promising expansion potential.
Maxwell Dee
Maxwell Dee
26 Aug 2025

Browse the archive

Full archive